Stock Track | Regencell Bioscience Soars 29% Following Stock Split, Extending 46,000% Year-to-Date Rally

Stock Track

Jun 18

Regencell Bioscience Limited (RGC) shares continued their extraordinary rally on Tuesday, soaring 29.13% in intraday trading. This surge follows the company's recent 38-for-1 forward stock split, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1141418675"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141418675\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141418675?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-18 03:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141418675","market":"hk","top_or_hot":-1,"title":"Stock Track | Regencell Bioscience Soars 29% Following Stock Split, Extending 46,000% Year-to-Date Rally","media":"Stock Track","content":"<div>\n<p>Regencell Bioscience Limited (RGC) shares continued their extraordinary rally on Tuesday, soaring 29.13% in intraday trading. This surge follows the company's recent 38-for-1 forward stock split, ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Regencell Bioscience Soars 29% Following Stock Split, Extending 46,000% Year-to-Date Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Regencell Bioscience Soars 29% Following Stock Split, Extending 46,000% Year-to-Date Rally\n</h2>\n\n<h4 class=\"meta\">\n\n2025-06-18 03:36 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regencell Bioscience Limited (RGC) shares continued their extraordinary rally on Tuesday, soaring 29.13% in intraday trading. This surge follows the company's recent 38-for-1 forward stock split, ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGC","symbol_name":"脑再生科技","start_time":0,"source_url":"","article_id":"1141418675","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141418675","pubTimestamp":1750189015,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Regencell Bioscience Limited  shares continued their extraordinary rally on Tuesday, soaring 29.13% in intraday trading. This surge follows the company's recent 38-for-1 forward stock split, which became effective on Monday and triggered increased trading activity. The biotech firm, focused on traditional Chinese medicine-based treatments for neurological disorders, has now seen its stock price skyrocket by over 46,000% year-to-date, despite having no revenue or profits.Despite its massive marke","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGC":"脑再生科技"},"translate_title":"股票赛道Regencell Bioscience股票分割后飙升29%，年初至今涨幅扩大46,000%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGC":1},"content_text":"Regencell Bioscience Limited (RGC) shares continued their extraordinary rally on Tuesday, soaring 29.13% in intraday trading. This surge follows the company's recent 38-for-1 forward stock split, which became effective on Monday and triggered increased trading activity. The biotech firm, focused on traditional Chinese medicine-based treatments for neurological disorders, has now seen its stock price skyrocket by over 46,000% year-to-date, despite having no revenue or profits.\nThe stock split, announced earlier this month, provided shareholders of record as of June 12 with 37 additional shares for every share held. Regencell stated that the split was intended to enhance market liquidity and make shares more accessible to investors. However, market observers urge caution, as the company's meteoric rise appears to be driven largely by speculative trading rather than fundamental developments.\nDespite its massive market valuation of nearly $30 billion, Regencell Bioscience has yet to generate any revenue or turn a profit. The company reported a net loss of $4.4 million for its fiscal year ending June 2024. The extreme volatility in the stock price, including multiple trading halts due to circuit breakers, highlights the risks associated with such speculative movements and raises questions about the sustainability of its current valuation. Investors should note that the company's tiny float, with only about 6% of shares available for trading, may contribute to the outsized price swings.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}